Literature DB >> 9716191

Management of conjunctival cicatrizing diseases and severe ocular surface dysfunction.

A G Chiou1, G J Florakis, M Kazim.   

Abstract

Physical or chemical injuries, infections, immunologic oculocutaneous disorders, drugs, and various systemic disorders may cause scarring of the conjunctiva and disturbances of the ocular surface. Trichiasis, lid margin malposition, and dry eye may result in persistent ocular irritation. The cornea may be primarily or secondarily involved. If severe, disturbances of the ocular surface may lead to significant visual impairment. Thorough evaluation of patients and of the underlying disease process is required for optimal management. Treatment may be challenging and should be comprehensive, combining medical measures and surgical correction of structural changes. Suppression of exogenous irritants, treatment of dry eye, antiinflammatory therapy, and immunosuppressants are paramount to control the underlying disease and allow optimal surgical results. Surgical correction of trichiasis and lid margin malposition, conjunctival grafting, mucous membrane transplantation, limbal stem cell transplantation, amniotic membrane transplantation, and penetrating keratoplasty help reestablish a physiologic ocular surface. Severe cases may require keratoprosthetics for visual rehabilitation. Corneal ulceration or perforation requires prompt attention to maintain ocular integrity. Special measures should be considered for patients who require cataract or glaucoma surgery.

Entities:  

Mesh:

Year:  1998        PMID: 9716191     DOI: 10.1016/s0039-6257(98)00005-8

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  15 in total

1.  Long term results after autologous nasal mucosal transplantation in severe mucus deficiency syndromes.

Authors:  H Wenkel; V Rummelt; G O Naumann
Journal:  Br J Ophthalmol       Date:  2000-03       Impact factor: 4.638

2.  Dapsone induced haemolytic anaemia in patients treated for ocular cicatricial pemphigoid.

Authors:  M S Wertheim; J J Males; S D Cook; D M Tole
Journal:  Br J Ophthalmol       Date:  2006-04       Impact factor: 4.638

Review 3.  Graft failure: II. Ocular surface complications.

Authors:  Samar A Al-Swailem
Journal:  Int Ophthalmol       Date:  2008-06       Impact factor: 2.031

4.  Ocular surface reconstruction with a tissue-engineered nasal mucosal epithelial cell sheet for the treatment of severe ocular surface diseases.

Authors:  Masakazu Kobayashi; Takahiro Nakamura; Makoto Yasuda; Yuiko Hata; Shoki Okura; Miyu Iwamoto; Maho Nagata; Nigel J Fullwood; Noriko Koizumi; Yasuo Hisa; Shigeru Kinoshita
Journal:  Stem Cells Transl Med       Date:  2014-11-19       Impact factor: 6.940

Review 5.  Autologous serum eye drops for ocular surface disorders.

Authors:  G Geerling; S Maclennan; D Hartwig
Journal:  Br J Ophthalmol       Date:  2004-11       Impact factor: 4.638

6.  Toward electron-beam sterilization of a pre-assembled Boston keratoprosthesis.

Authors:  Sina Sharifi; Hannah Sharifi; Curtis Guild; Mohammad Mirazul Islam; Khoa D Tran; Corrina Patzer; Claes H Dohlman; Eleftherios I Paschalis; Miguel Gonzalez-Andrades; James Chodosh
Journal:  Ocul Surf       Date:  2021-03-03       Impact factor: 5.033

7.  Conjunctival reconstruction with progenitor cell-derived autologous epidermal sheets in rhesus monkey.

Authors:  Rong Lu; Xinchun Zhang; Danping Huang; Bing Huang; Nan Gao; Zhichong Wang; Jian Ge
Journal:  PLoS One       Date:  2011-11-11       Impact factor: 3.240

8.  Omental transposition in treatment of severe ocular surface alkaline burn: an experimental study.

Authors:  Athar Shadmani; Kourosh Kazemi; Mohammad Reza Khalili; Masoomeh Eghtedari
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2014

Review 9.  The eyelash follicle features and anomalies: A review.

Authors:  Sarah Aumond; Etty Bitton
Journal:  J Optom       Date:  2018-07-17

10.  DNA methyltransferase inhibitor suppresses fibrogenetic changes in human conjunctival fibroblasts.

Authors:  Hitomi Yonemura; Akiko Futakuchi; Miyuki Inoue-Mochita; Tomokazu Fujimoto; Eri Takahashi; Hidenobu Tanihara; Toshihiro Inoue
Journal:  Mol Vis       Date:  2019-07-21       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.